Ausgabe 3/2009
Inhalt (26 Artikel)
Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients
Balazs Györffy, Reinhold Schäfer
Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor α (ERα) in tissue microarrays of ERα positive human breast carcinomas
George P. Skliris, Brian G. Rowan, Mariam Al-Dhaheri, Christopher Williams, Sandy Troup, Sanela Begic, Michelle Parisien, Peter H. Watson, Leigh C. Murphy
Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR
Anieta M. Sieuwerts, Jaco Kraan, Joan Bolt-de Vries, Petra van der Spoel, Bianca Mostert, John W. M. Martens, Jan-Willem Gratama, Stefan Sleijfer, John A. Foekens
Opposite effects of protein kinase C beta1 (PKCβ1) and PKCε in the metastatic potential of a breast cancer murine model
Valeria C. Grossoni, Laura B. Todaro, Marcelo G. Kazanietz, Elisa D. Bal de Kier Joffé, Alejandro J. Urtreger
A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines
Alan Mackay, Narinder Tamber, Kerry Fenwick, Marjan Iravani, Anita Grigoriadis, Tim Dexter, Christopher J. Lord, Jorge S. Reis-Filho, Alan Ashworth
Stimulation of the bradykinin B1 receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway
Luis Molina, Carola E. Matus, Angel Astroza, Francisca Pavicic, Eugenio Tapia, Cesar Toledo, Juan A. Perez, Francisco Nualart, Carlos B. Gonzalez, Rafael A. Burgos, Carlos D. Figueroa, Pamela Ehrenfeld, Maria T. Poblete
Reporting of race and ethnicity in breast cancer research: room for improvement
Kelly W. Mitchell, Lisa A. Carey, Jeffrey Peppercorn
‘Minority report’: how best to analyze clinical trial data to address disparities
Dawn L. Hershman, Joseph M. Unger
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
Marta Pestrin, Silvia Bessi, Francesca Galardi, Mara Truglia, Annibale Biggeri, Chiara Biagioni, Silvia Cappadona, Laura Biganzoli, Augusto Giannini, Angelo Di Leo
Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users
A. S. Dieudonné, D. Lambrechts, B. Claes, T. Vandorpe, H. Wildiers, D. Timmerman, J. Billen, K. Leunen, F. Amant, P. Berteloot, A. Smeets, R. Paridaens, C. Weltens, E. Van Limbergen, W. Van den Bogaert, I. Vergote, S. Van Huffel, M. R. Christiaens, P. Neven
Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence
P. Shah, M. Rosen, J. Stopfer, J. Siegfried, R. Kaltman, B. Mason, K. Armstrong, K. L. Nathanson, M. Schnall, S. M. Domchek
Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling
Julie Lemieux, Carl Amireault, Louise Provencher, Elizabeth Maunsell
Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status
Min Zhang, Hongjian Yang, C. D’Arcy J. Holman
Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk
Daniele Campa, James McKay, Olga Sinilnikova, Anika Hüsing, Ulla Vogel, Rikke Dalgaard Hansen, Kim Overvad, Petra Mariann Witt, Françoise Clavel-Chapelon, Marie-Christine Boutron-Ruault, Veronique Chajes, Sabine Rohrmann, Jenny Chang-Claude, Heiner Boeing, Eva Fisher, Antonia Trichopoulou, Dimitrios Trichopoulos, Domenico Palli, Anna Villarini, Carlotta Sacerdote, Amalia Mattiello, Rosario Tumino, Petra H. M. Peeters, Carla H. van Gils, H. Bas Bueno-de-Mesquita, Eiliv Lund, María Dolores Chirlaque, Núria Sala, Laudina Rodriguez Suarez, Aurelio Barricarte, Miren Dorronsoro, Maria-José Sánchez, Per Lenner, Göran Hallmans, Kostas Tsilidis, Sheila Bingham, Kay-Tee Khaw, Valentina Gallo, Teresa Norat, Elio Riboli, Sabina Rinaldi, Gilbert Lenoir, Sean V. Tavtigian, Federico Canzian, Rudolf Kaaks
No evidence of familial correlation in breast cancer metastasis
Alice S. Whittemore, Beth Stearman, Vickie Venne, Jerry Halpern, Anna Felberg, Valerie McGuire, Mary Daly, Saundra S. Buys
Accuracy of self-reported breast cancer among women undergoing mammography
Linn Abraham, Berta M. Geller, Bonnie C. Yankaskas, Erin J. A. Bowles, Leah S. Karliner, Stephen H. Taplin, Diana L. Miglioretti
Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study
Mike G. Martin, John S. Welch, Jingqin Luo, Matthew J. Ellis, Timothy A. Graubert, Matthew J. Walter
STK15 F31I polymorphism is associated with breast cancer risk: a meta-analysis involving 25,014 subjects
Li-Xin Qiu, Bo Chen, Chen Mao, Ping Zhan, Hui Yuan, Kai Xue, Jin Li, Xi-Chun Hu
Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERα
Le Lam, Xiuying Hu, Zackie Aktary, David W. Andrews, Manijeh Pasdar
Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality?
F. Didier, D. Radice, S. Gandini, R. Bedolis, N. Rotmensz, A. Maldifassi, B. Santillo, A. Luini, V. Galimberti, E. Scaffidi, F. Lupo, S. Martella, J. Y. Petit
Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care
Christopher L. Tebbit, Jun Zhai, Brian R. Untch, Matthew J. Ellis, Holly K. Dressman, Rex C. Bentley, Jay A. Baker, Paul K. Marcom, Joseph R. Nevins, Jeffrey R. Marks, John A. Olson Jr.
Genomic analysis from tissue core biopsies: standard of care for the future?
Sudipa Sarkar, David P. Tuck, Lyndsay N. Harris
Caution regarding genotyping methodology for a tri-allelic polymorphism in the novel breast cancer susceptibility gene NQO2
Ke-Da Yu, Gen-Hong Di, Lei Fan, Zhen Hu, Ao-Xiang Chen, Zhi-Ming Shao
Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer
Najim Ameziane, Ans M. W. van den Ouweland, Muriel A. Adank, Raymond N. C. P. Vijzelaar, Abdellatif Errami, Josephine C. Dorsman, Hans Joenje, Hanne Meijers-Heijboer, Quinten Waisfisz
The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features
E. Barroso, G. Pita, J. I. Arias, P. Menendez, P. Zamora, M. Blanco, J. Benitez, G. Ribas
The immunohistochemically “ER-negative, PR-negative, HER2-negative, CK5/6-negative, and HER1-negative” subgroup is not a surrogate for the normal-like subtype in breast cancer
Ke-Da Yu, Zhen-Zhou Shen, Zhi-Ming Shao